Markets › India › NSE › ALKEM

Alkem Laboratories Ltd

NSE:ALKEMHealthcareNSE:CNX500NSE:CNXPHARMA

₹5,004.00−0.91%At closeAt close · Mon 19 Oct · ≈ AED 193.07 · Market cap $6.39B · Next earnings Fri 6 Nov

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	Current · undated	YoY
Gross margin	58.9%	59.3%	56.4%	59.5%	62.1%	65.4%	—	—
Operating margin	19.1%	16.8%	11.7%	16.0%	17.1%	17.8%	17.8%	+0.0 pts
Net margin	18.2%	15.7%	8.6%	14.4%	16.9%	15.6%	19.5%	+3.9 pts
EBITDA margin	24.8%	20.8%	14.9%	19.4%	23.2%	23.2%	—	—
Return on equity	21.5%	19.1%	10.9%	17.4%	18.1%	16.7%	20.0%	+3.4 pts
Return on assets	13.8%	11.7%	7.2%	11.5%	12.2%	11.0%	13.8%	+2.7 pts
Return on capital employed	21.1%	19.1%	13.3%	17.1%	15.9%	16.3%	—	—
Debt / equity	0.2×	0.3×	0.2×	0.1×	0.1×	0.1×	0.1×	−3.7%
Debt / assets	15.6%	19.0%	10.2%	9.1%	7.8%	9.8%	—	—
Interest coverage	28.4×	41.7×	12.4×	20.4×	20.8×	16.3×	—	—
Current ratio	1.9×	1.8×	2.4×	2.6×	2.8×	2.6×	2.6×	+0.0%
Quick ratio	1.3×	1.1×	1.7×	1.9×	2.0×	1.9×	—	—
Cash ratio	0.0×	0.0×	0.1×	0.1×	0.1×	0.1×	0.1×	+0.0%
Asset turnover	0.8×	0.7×	0.8×	0.8×	0.7×	0.7×	—	—
Inventory turnover	1.6×	1.4×	1.9×	1.9×	1.7×	1.5×	—	—
Receivables turnover	5.4×	5.1×	4.9×	5.4×	5.2×	4.9×	—	—
Dividend payout	21.1%	25.6%	53.8%	30.0%	23.3%	26.7%	—	—